Translational Development Acquisition Corp.
TDAC · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | |
|---|---|---|---|
| Assets | – | – | – |
| Cash & Equivalents | $438 | $2 | $2 |
| Short-Term Investments | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 |
| Other Curr. Assets | $212 | $0 | $52 |
| Total Curr. Assets | $650 | $2 | $54 |
| Property Plant & Equip (Net) | $0 | $0 | $0 |
| Goodwill | $9,061,675,000 | $0 | $0 |
| Intangibles | $12,569,165,000 | $0 | $0 |
| Long-Term Investments | $174,350 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 |
| Other NC Assets | -$21,630,840,000 | $0 | $383 |
| Total NC Assets | $174,350 | $0 | $383 |
| Other Assets | $0 | $0 | $0 |
| Total Assets | $175,001 | $2 | $437 |
| Liabilities | – | – | – |
| Payables | $16 | $1 | $0 |
| Short-Term Debt | $6,110,777,000 | $348 | $259 |
| Tax Payable | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 |
| Other Curr. Liab. | -$6,110,776,806 | $161 | $200 |
| Total Curr. Liab. | $210 | $510 | $459 |
| LT Debt | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 |
| Other NC Liab. | $6,038 | $0 | $0 |
| Total NC Liab. | $6,038 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 |
| Total Liabilities | $6,248 | $510 | $459 |
| Equity | – | – | – |
| Pref Stock | $0 | $0 | $0 |
| Common Stock | $18,327,000 | $0 | $0 |
| Retained Earnings | -$5,598 | -$533 | -$47 |
| AOCI | $16,880,000 | $0 | $0 |
| Other Equity | -$35,032,649 | $25 | $25 |
| Total Equity | $168,753 | -$508 | -$22 |
| Supplemental Information | – | – | – |
| Minority Interest | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $175,001 | $2 | $437 |
| Net Debt | $6,110,776,562 | $345 | $257 |